Aveanna Healthcare said it has repriced its first lien credit facility and revolving credit facility, lowering applicable interest rate margins by 50 basis points.
The company said it could secure an additional 25-basis-point reduction if the borrower obtains a credit rating of at least B2 or B from certain rating agencies.
Chief Financial Officer Matt Buckhalter said the move supports efforts to strengthen the balance sheet and adds flexibility for the company’s growth plans.
The announcement did not include the size of the debt facilities, the company’s current interest expense, or any changes to revenue, profit, or cash flow. As a result of these announcements, the company's shares have moved 1.57% on the market, and are now trading at a price of $7.455. If you want to know more, read the company's complete 8-K report here.
